Vaccines
Page 1 • 4 itemsGlobal vaccine market intelligence for pharma BD, investors & analysts. Stay ahead with critical regulatory updates & competitive insights.
Emergent BioSolutions Partners with Substipharm for $34.5M Japanese Encephalitis Vaccine Manufacturing Deal
Emergent BioSolutions announces $34.5M partnership with Substipharm Biologics to manufacture IMOJEV Japanese encephalitis vaccine for U.S. government distribution.
FDA Approval mRNA Vaccine RSV: Market Impact & Future Outlook
The FDA's approval of the mRNA vaccine for RSV marks a significant advancement in respiratory syncytial virus prevention, with profound market implications and future potential.
FDA Approval ResVax: Comprehensive Market Analysis of Novel mRNA RSV Vaccine
This article provides a comprehensive market analysis of ResVax, the newly FDA-approved mRNA vaccine targeting respiratory syncytial virus (RSV).
FDA Approves V-Protect Vaccine: Key Details on ViroDefense’s New Tool
ViroDefense's newly approved V-Protect vaccine promises to bolster immunity against viral infections, marking a significant advancement in public health.